title: Clinical Genetics Testing Laboratories Have a Remarkably Low Rate of Clinically Significant Discordance When Interpreting Variants in Hereditary Cancer Syndrome Genes.
authors.affiliation: Robert L. Nussbaum, Invitae Corporation and University of California San Francisco, San Francisco, CA; and Shan Yang and Stephen E. Lincoln, Invitae Corporation, San Francisco, CA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Nussbaum
authors.affiliation: Robert L. Nussbaum, Invitae Corporation and University of California San Francisco, San Francisco, CA; and Shan Yang and Stephen E. Lincoln, Invitae Corporation, San Francisco, CA.
authors.forename: Shan
authors.initials: S
authors.lastname: Yang
authors.affiliation: Robert L. Nussbaum, Invitae Corporation and University of California San Francisco, San Francisco, CA; and Shan Yang and Stephen E. Lincoln, Invitae Corporation, San Francisco, CA.
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Lincoln
mesh_terms: D005820:Genetic Testing; D006801:Humans; D007753:Laboratories; D009386:Neoplastic Syndromes, Hereditary / Q000235:genetics*; D011446:Prospective Studies; D012042:Registries